Monguzzi R, Pinza M, Pifferi G, Visconti M, Broccali G
Farmaco Sci. 1985 Dec;40(12):956-69.
Using as a model cephalosporins with an alpha-hydroxyimino moiety in the side chain, some new (E)-alpha-hydrazono and alpha-methylhydrazono benzyl cephalosporins were prepared. While the synthesis of methylhydrazono-derivatives (I a-d) involved direct condensation of the methylhydrazionacid (II a-b) with a protected 7-aminocephalosporanic derivative, the N-unsubstituted compounds (I e-f) had to be prepared from the N-acyl protected hydrazono acids (III a-d). The cephalosporin (I f) was also obtained as Z-isomer by condensation of the corresponding alpha-oxo compound with 4-nitrobenzyloxycarbonylhydrazine, chromatographic separation of the obtained E-Z mixture, and hydrogenolysis of the Z form. The in vitro antibacterial evaluation showed that N-methyl substitution is favorable among the E compounds, whereas among the N-unsubstituted hydrazono derivatives, the compound Z-(I f), although less stable, is much more potent than the corresponding E-isomer.
以侧链带有α-羟基亚氨基部分的头孢菌素为模型,制备了一些新的(E)-α-腙基和α-甲基腙基苄基头孢菌素。虽然甲基腙基衍生物(I a-d)的合成涉及甲基肼酸(II a-b)与受保护的7-氨基头孢烷酸衍生物的直接缩合,但N-未取代的化合物(I e-f)必须由N-酰基保护的腙基酸(III a-d)制备。头孢菌素(I f)也通过相应的α-氧代化合物与4-硝基苄氧基羰基肼缩合、所得E-Z混合物的色谱分离以及Z型的氢解以Z-异构体形式获得。体外抗菌评估表明,在E化合物中N-甲基取代是有利的,而在N-未取代的腙基衍生物中,化合物Z-(I f)虽然稳定性较差,但比相应的E-异构体活性要强得多。